Homology Medicines
(NASDAQ) FIXX
Homology Medicines Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$29.82M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
FIXX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Homology Medicines
Industry
Biotechnology
Sector
Health CareEmployees
24
CEO
Jodie P. Morrison
Website
www.q32bio.comHeadquarters
Bedford, MA 01730, US
FIXX Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
31%
Net Income Margin
55%
Return on Equity
16%
Return on Capital
34%
Return on Assets
48%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$16.90M
EBITDA
$16.90M
Operating Cash Flow
$33.54M
Capital Expenditure
$2.00K
Free Cash Flow
$33.54M
Cash & ST Invst.
$48.30M
Total Debt
$11.18M
Homology Medicines Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
+100.0%
Gross Profit
$0.00
-100.0%
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
7
N/A
Net Income
$57.73M
+2818.6%
EBITDA
$45.88M
+366.2%
Quarterly Fundamentals
Net Cash
$37.12M
-46.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$4.94M
-12.3%
Short Term Debt
$6.24M
+101.3%
Return on Assets
48.27%
N/A
Return on Invested Capital
33.52%
N/A
Free Cash Flow
$0.00
+100.0%
Operating Cash Flow
$0.00
+100.0%